2E,6E-farnesol

2e,6e-farnesol is a lipid of Prenol Lipids (PR) class. 2e,6e-farnesol is associated with abnormalities such as Granulomatous Disease, Chronic, pathologic fistula and Cavitation. The involved functions are known as Regulation, Metabolic Inhibition, cholesterol biosynthetic process, Process and Transcription, Genetic. 2e,6e-farnesol often locates in Plasma membrane, Cytoplasmic matrix, cornified envelope, Epidermis and peroxisome. The associated genes with 2E,6E-farnesol are RAB3A gene, FOSL1 gene, CASP8AP2 gene, RCC1 gene and GALE gene. The related lipids are Sterols, Membrane Lipids and Steroids.

Cross Reference

Introduction

To understand associated biological information of 2E,6E-farnesol, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with 2E,6E-farnesol?

2E,6E-farnesol is suspected in Granulomatous Disease, Chronic, pathologic fistula and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 2E,6E-farnesol

MeSH term MeSH ID Detail
Anisakiasis D017129 2 associated lipids
Candidiasis, Invasive D058365 2 associated lipids
Neuritis, Autoimmune, Experimental D009444 4 associated lipids
Nerve Sheath Neoplasms D018317 4 associated lipids
Head Injuries, Closed D016489 5 associated lipids
Hypergammaglobulinemia D006942 9 associated lipids
Neurilemmoma D009442 10 associated lipids
Meningioma D008579 11 associated lipids
Candidiasis, Oral D002180 11 associated lipids
Neoplasms, Glandular and Epithelial D009375 12 associated lipids
Per page 10 20 50 | Total 42

PubChem Associated disorders and diseases

What pathways are associated with 2E,6E-farnesol

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with 2E,6E-farnesol?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with 2E,6E-farnesol?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with 2E,6E-farnesol?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with 2E,6E-farnesol?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with 2E,6E-farnesol?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with 2E,6E-farnesol

Download all related citations
Per page 10 20 50 100 | Total 950
Authors Title Published Journal PubMed Link
Kotti T et al. Biphasic requirement for geranylgeraniol in hippocampal long-term potentiation. 2008 Proc. Natl. Acad. Sci. U.S.A. pmid:18685105
Jackson JH et al. Farnesol modification of Kirsten-ras exon 4B protein is essential for transformation. 1990 Proc. Natl. Acad. Sci. U.S.A. pmid:2183224
Peleg AY et al. Prokaryote-eukaryote interactions identified by using Caenorhabditis elegans. 2008 Proc. Natl. Acad. Sci. U.S.A. pmid:18794525
Mayoral JG et al. NADP+-dependent farnesol dehydrogenase, a corpora allata enzyme involved in juvenile hormone synthesis. 2009 Proc. Natl. Acad. Sci. U.S.A. pmid:19940247
Fisher JE et al. Alendronate mechanism of action: geranylgeraniol, an intermediate in the mevalonate pathway, prevents inhibition of osteoclast formation, bone resorption, and kinase activation in vitro. 1999 Proc. Natl. Acad. Sci. U.S.A. pmid:9874784
Parmryd I et al. Protein prenylation in spinach chloroplasts. 1999 Proc. Natl. Acad. Sci. U.S.A. pmid:10468564
Lai RK et al. The gamma subunit of transducin is farnesylated. 1990 Proc. Natl. Acad. Sci. U.S.A. pmid:2217200
Casey PJ et al. p21ras is modified by a farnesyl isoprenoid. 1989 Proc. Natl. Acad. Sci. U.S.A. pmid:2682646
Jautelat M et al. Natural-abundance 13C nuclear magnetic resonance spectra of terpenes and carotenes. 1970 Proc. Natl. Acad. Sci. U.S.A. pmid:5263764
Cornforth J Symmetry of squalene epoxidation in vivo. 1977 Proc. R. Soc. Lond., B, Biol. Sci. pmid:22855
Donninger C and Popják G Studies on the biosynthesis of cholesterol. 18. The stereospecificity of mevaldate reductase and the biosynthesis of asymmetrically labelled farnesyl pyrophosphate. 1966 Proc. R. Soc. Lond., B, Biol. Sci. pmid:4379290
McPherson RA et al. The novel Ras antagonist, farnesylthiosalicylate, suppresses growth of prostate cancer in vitro. 2004 Prostate pmid:14968433
Banfi C et al. Proteomic analysis of human low-density lipoprotein reveals the presence of prenylcysteine lyase, a hydrogen peroxide-generating enzyme. 2009 Proteomics pmid:19253276
Blum R et al. Inhibitors of chronically active ras: potential for treatment of human malignancies. 2008 Recent Pat Anticancer Drug Discov pmid:18289122
Jahangir T et al. Alleviation of free radical mediated oxidative and genotoxic effects of cadmium by farnesol in Swiss albino mice. 2005 Redox Rep. pmid:16438802
Lima JP et al. [Gefarnate (DA-688) in the treatment of peptic ulcer; immediate results]. 1966 Rev Bras Med pmid:5940586
Mincis M [Clinical study of the effect of geranyl of farnesylacetate combined with nafiver in peptic ulcer patients]. 1968 Rev Bras Med pmid:5724217
Pastor Franco A [Clinicobiological evolution of duodenal ulcer treated with gefarnate]. 1966 Rev Clin Esp pmid:4286000
Marcos Becerro JF and Rodriguez Gorostiza FJ [The effect of farnesyl geranyl acetate on duodenal ulcer]. 1968 Rev Esp Enferm Apar Dig pmid:5670667
Akisue G [Secretion of Myroxylon peruiforum L.f. 3. Physical and chemical characterization of essential oil from balsam and qualitative analysis of various componets]. 1972 Jul-Dec Rev Farm Bioquim Univ Sao Paulo pmid:4664898
Styczyńska B and Krzemińska A [Laboratory testing of control of the Monomorium pharaonis L. ants with the use of juvenile hormones]. 1981 Rocz Panstw Zakl Hig pmid:7313455
Styczyńska B et al. [Biological activity of the Polish juvenile hormone cyclopren tested on various Diptera species]. 1980 Rocz Panstw Zakl Hig pmid:7466235
Krzemińska A et al. [Field studies on the effectiveness of insecticides containing juvenile hormones against the ant Monomorium pharaonis L]. 1983 Rocz Panstw Zakl Hig pmid:6612185
Styczyńska B and Sereda B [Effect of hormone-like substances on the gonads of domestic fly (Musca domestica L.)]. 1979 Rocz Panstw Zakl Hig pmid:515638
Styczyńska B et al. [Assessment of the activity of insect hormone analogues. I. Derivatives of 2,3-methylenefarnesol and 2,3-methylenefarnesenic acid]. 1974 Rocz Panstw Zakl Hig pmid:4842239
Crick DC et al. Geranylgeraniol restores cell proliferation to lovastatin treated C6 glial cells. 1996 SAAS Bull. Biochem. Biotechnol. pmid:8652130
Ilayaraja R et al. Evaluating the binding efficiency of pheromone binding protein with its natural ligand using molecular docking and fluorescence analysis. 2014 Sci Rep pmid:24903953
Graebe JE Isoprenoid biosynthesis in a cell-free system from pea shoots. 1967 Science pmid:4381746
Pei ZM et al. Role of farnesyltransferase in ABA regulation of guard cell anion channels and plant water loss. 1998 Science pmid:9765153
Fukui S [Sexual differentiation in heterobasidiomycetous yeasts (author's transl)]. 1980 Seikagaku pmid:7019358
Yasugi E [Induction of apoptosis by isoprenoids]. 1999 Seikagaku pmid:10659677
Zhang X et al. Nanomicellar carriers for targeted delivery of anticancer agents. 2014 Ther Deliv pmid:24341817
Binet L et al. [Farnesol, psychosedative and spasmolytic drug]. 1972 Sep-Oct Therapie pmid:4405589
Mussoni L et al. Fluvastatin inhibits basal and stimulated plasminogen activator inhibitor 1, but induces tissue type plasminogen activator in cultured human endothelial cells. 2000 Thromb. Haemost. pmid:10928471
Saito K et al. An in vitro skin sensitization assay termed EpiSensA for broad sets of chemicals including lipophilic chemicals and pre/pro-haptens. 2017 Toxicol In Vitro pmid:27965148
Flint OP et al. Inhibition of cholesterol synthesis by squalene synthase inhibitors does not induce myotoxicity in vitro. 1997 Toxicol. Appl. Pharmacol. pmid:9221828
Lemaire B et al. Cytochrome P450 20A1 in zebrafish: Cloning, regulation and potential involvement in hyperactivity disorders. 2016 Toxicol. Appl. Pharmacol. pmid:26853319
Yang SP and Raner GM Cytochrome P450 expression and activities in human tongue cells and their modulation by green tea extract. 2005 Toxicol. Appl. Pharmacol. pmid:15629189
Winn LM and Wells PG Evidence for Ras-dependent signal transduction in phenytoin teratogenicity. 2002 Toxicol. Appl. Pharmacol. pmid:12460742
Schleimer K et al. Competition between native liver and graft in auxiliary liver transplantation in a rat model. 2008 Transplant. Proc. pmid:18555091
Teodoro JS et al. Hepatic FXR: key regulator of whole-body energy metabolism. 2011 Trends Endocrinol. Metab. pmid:21862343
Iazlovitskaia EM et al. Human leukemia CEM C-1 cells possess a high affinity binding site for farnesol. 1997 Mar-Apr Ukr. Biokhim. Zh. pmid:9463231
Cordeiro Rde A et al. Farnesol inhibits in vitro growth of the Cryptococcus neoformans species complex with no significant changes in virulence-related exoenzymes. 2012 Vet. Microbiol. pmid:22580194
Nowak M and Kurnatowski P [Biofilm caused by fungi--structure, quorum sensing, morphogenetic changes, resistance to drugs]. 2009 Wiad Parazytol pmid:19579780
Styczyńska B et al. [2,3-methylenefarnesenic acid derivatives as juvenile hormone analogs against housefly (Musca domestica L.)]. 1977 Wiad Parazytol pmid:899003
Weber K et al. The quorum-sensing molecule E,E-farnesol--its variable secretion and its impact on the growth and metabolism of Candida species. 2010 Yeast pmid:20641010
Uppuluri P et al. Farnesol-mediated inhibition of Candida albicans yeast growth and rescue by a diacylglycerol analogue. 2007 Yeast pmid:17583896
Saidi S et al. In vitro synergistic effect of farnesol and human gingival cells against Candida albicans. 2006 Yeast pmid:16845684
Hintze-Podufal C The juvenile hormone-like effect of farnesol derivatives on the pupal development of Cerura vinula L. 1971 Z. Naturforsch. B pmid:4396584
Metzler M et al. On the biosynthesis of juvenile hormone in the adult Cecropia moth. 1971 Z. Naturforsch. B pmid:4401880